Young Investigator Award

The Cutaneous Lymphoma Foundation offers two Young Investigator Awards each year to new physicians and scientists in the field of cutaneous lymphoma research.

Since 2003, this annual award has been given to support travel to the Society for Investigative Dermatology (SID) Annual Meeting and participation in the concurrent CTCL Symposium. Due to the positive response of the initial award in 2011, we began offering a second award to an investigator presenting at the American Society of Hematology (ASH) Annual Meeting.

Criteria for selection of the Young Investigator Award includes:

  • Individuals with a MD or PhD degree.
  • Individuals with an academic rank no greater than assistant professor.
  • Individuals with demonstrable interest and/or achievement in clinical care, education or research in cutaneous lymphomas.
  • Individuals who have submitted an abstract and will presenting research at the either the ASH or SID annual meeting.

About Our 2018 International Investigative Dermatology Young Investigator Award Recipient

Every five years the Society of Investigative Dermatology (SID) joins the European Society for Dermatological Research (ESDR) and the Japanese Society for Investigative Dermatology (JSID) to host the International Investigative Dermatology (IID) meeting in place of its annual national meeting. This international research meeting attracts scientists throughout the world. The Cutaneous Lymphoma Foundation is pleased to announce Carina Dehner, MD, as the recipient of its 2018 Young Investigator Award (YIA) travel grant to the 2018 IID Meeting. Dr. Dehner is a Postdoctoral Associate in the Department of Immunology/Kriegel Lab at Yale's School of Medicine. Her research focuses on identifying skin commensals as instigators of cutaneous T-cell lymphoma. 


About Our 2017 American Society of Hematology Young Investigator Award Recipient

The Cutaneous Lymphoma Foundation is pleased to announce Bethany Mundy-Bosse, PhD, as the recipient of the 2017 Young Investigator Award for travel to present her research at the American Society of Hematology (ASH) annual meeting. Dr. Mundy-Bosse is a Research Assistant Professor in the Division of Hematology at Ohio State University in Columbus, Ohio. Her awarded research proposes a relationship between the increased expression of interleukin (IL)-15 in malignant CD4+ T cells in CTCL patients and NK cells. Her findings suggest further investigations aimed at understanding the disconnect between NK cell numbers, activation, and disease control in CTCL patients are warranted.